Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antineoplastic agent |
| gptkbp:activeIn |
gptkb:Trypanosoma_brucei_gambiense
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
|
| gptkbp:ATCCode |
P01CX04
|
| gptkbp:CASNumber |
59729-37-2
|
| gptkbp:chemicalFormula |
C15H13F2N3O3S
|
| gptkbp:developedBy |
gptkb:Sanofi
|
| gptkbp:discoveredBy |
gptkb:Hoechst_AG
|
| gptkbp:discoveredIn |
1977
|
| https://www.w3.org/2000/01/rdf-schema#label |
fexinidazole
|
| gptkbp:KEGGID |
D10541
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
nitroimidazole derivative
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2103837
3083545 DB12411 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting anorexia headache insomnia |
| gptkbp:synonym |
Fexinidazol
|
| gptkbp:UNII |
6V4744U5S7
|
| gptkbp:usedFor |
treatment of sleeping sickness
treatment of human African trypanosomiasis |
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:Trypanosoma_brucei_gambiense
gptkb:DNDi |
| gptkbp:bfsLayer |
7
|